mHealth applications integrated into ERAS protocols may improve adherence, recovery quality, and patient engagement without increasing adverse outcomes. However, the overall quality of evidence remains limited due to heterogeneity and a predominance of non-randomized studies.
D’Ambrosio et al. (Thu,) studied this question.